HAVN Life Sciences's total assets for Q4 2022 were C$4.06M, an increase of 1921.43% from the previous quarter. HAVLF total liabilities were C$918.46K for the fiscal quarter, a -16.27% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
